Men with metastatic prostate cancer treated with androgen deprivation therapy often experience metabolic damage like diabetes and fatty liver disease.

“men that present with metastatic prostate cancer they get they're treated with androgen deprivation therapy and the psa becomes normal or undetectable in 90 plus percent of the of these of these men and of course what do we do we just keep treating with androgen deprivation therapy i think which by the way says nothing about the metabolic damage and the total metabolic derangement it it brings on those men so if they don't die from prostate cancer they're going to die from diabetes and yeah the complications of fatty liver disease”